Euroapi (LTS:0EAP) Debt-to-Asset : 0.26 (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Euroapi Debt-to-Asset?

Euroapi's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €457.1 Mil. Euroapi's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €14.5 Mil. Euroapi's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was €1,795.9 Mil. Euroapi's debt to asset for the quarter that ended in Jun. 2024 was 0.26.

Euroapi Debt-to-Asset Historical Data

The historical data trend for Euroapi's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroapi Debt-to-Asset Chart

Euroapi Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

0.04

0.05

0.02

0.07

0.14

Euroapi Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-Asset	Get a 7-Day Free Trial				0.03	0.07	0.12	0.14	0.26

Competitive Comparison of Euroapi's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Euroapi's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Euroapi's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Euroapi's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Euroapi's Debt-to-Asset falls into.

Euroapi Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Euroapi's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(210	+	15.5)	/	1612.4
	=	0.14

Euroapi's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(457.1	+	14.5)	/	1795.9
	=	0.26

Euroapi (LTS:0EAP) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Euroapi Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Euroapi's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Euroapi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (LTS:0EAP) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

EAPIp:UK EAPI:France 940:Germany

Address

15 rue Traversiere, Paris, FRA, 75012

Website

https://www.euroapi.com

Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.

Euroapi Headlines

No Headlines